PATENT CLAIM ANALYSIS

Application Number: 15900019
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["435", "006000"]

Abstract:
Compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein ring A, ring B, W, m, R 2 , R 2a , R 3 , R 3a , and Z are as defined herein, are inhibitors of Trk kinases and are useful in the treatment of pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.

Claim (Index 15):
The method of  claim 2 , wherein the cancerous tumor exhibits overexpression of a Trk kinase.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.57143
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14575663', '13698922', '15350888', '15401952', '15401839']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7519788920652193
- 35 USC 102 Novelty (BERT): 0.5452827583897872
- Combined Prediction Score: 0.731309278697676
- Mean Citation Score: 523.9771599999998
- Max Citation Score: 538.8581
- Similarity Product: 328.45253941112765

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test